2 min read
Connect with Veristat at Bio International Convention 2026
June 22-25, 2026 – San Diego, CA
🌎 Bringing the Global Biopharma Community Together
We’re delighted to be attending...
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.
Learning Points
- What are Drug Device Combination (DDC) products
- What is Article 117 of the MDR
- The impact of Article 117 on Manufacturers
Meet Veristat. Learn More.
Get the Latest News
Categories
- Regulatory Consulting (137)
- Regulatory Submissions (132)
- Clinical Trial Regulations (121)
- COVID-19 (46)
- Strategic Consulting (40)
- Clinical Trials (35)
- Life At Veristat (21)
- Oncology (18)
- Events (16)
- Success Stories (13)
- Clinical Operations/Monitoring (12)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Full-Service (9)
- Medical Writing (9)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Neurology/CNS (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Psychedelics (2)
- Rare Diseases (2)
- Hematology (1)
- Medical Affairs (1)
2 min read
Connect with Veristat at DIA 2026
Jun 5, 2026 Veristat Events
June 14-18, 2026 – Philadelphia, PA
Veristat is excited to join industry leaders and innovators at the DIA 2026 Global...